2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Abstract

limb salvage ◼ smoking cessation AHA/ACC GUIDELINE ACC/AHA Task Force Members, see page e707 *Writing committee members are required to recuse themselves from voting on sections to which their specific relationships with industry and other entities may apply; see Appendix 1 for recusal information.†Functioning as the lay volunteer/patient representative.‡ACC/AHA Representative.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 324

1. 1.

   Clinical Practice Guidelines We Can Trust. 2011.

   Not in our library

2. 2.

   Eden J. Finding What Works in Health Care: Standards for Systematic Reviews. 2011.

   Not in our library

3. 3.

   Methodology Manual and Policies From the ACCF/AHA Task Force on Practice Guidelines. 2010.

   Not in our library

4. 4.

   Halperin JL, Levine GN, Al-Khatib SM, et al. Further evolution of the ACC/AHA clinical practice guideline recommendation classification system: a report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2016;133:1426-28.

   Not in our library10.1161/cir.0000000000000312

5. 5.

   Jacobs AK, Kushner FG, Ettinger SM, et al. ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127:268-310.

   Not in our library10.1161/cir.0b013e31827e8e5f

6. 6.

   Jacobs AK, Anderson JL, Halperin JL. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;130:1208-17-1373-84.

   Not in our library10.1016/j.jacc.2014.06.001

7. 7.

   Anderson JL, Heidenreich PA, Barnett PG, et al. ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. Circulation. 2014;130:1662-7.

   Not in our library

8. 8.

   Arnett DK, Goodman RA, Halperin JL, et al. AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and U.S. Department of Health and Human Services. Circulation. 2014;130:1662-7.

   Not in our library10.1161/cir.0000000000000128

9. 9.
   2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines · 2017

   Corrected
10. 10.

    Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary: a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease). Circulation. 2006;113:e463-654.

    Not in our library10.1161/circulationaha.106.174526

11. 11.

    Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2011;124:2020-45.

    Not in our library10.1161/cir.0b013e31822e80c3

12. 12.

    Jones WS, Schmit KM, Vemulapalli S, et al. Treatment Strategies for Patients With Peripheral Artery Disease. Comparative Effectiveness Review No 118 The Duke Evidence-based Practice Center under Contract No 290-2007-10066-I. 2013.

    Not in our library

13. 13.

    Vemulapalli S, Dolor RJ, Hasselblad V, et al. Comparative effectiveness of medical therapy, supervised exercise, and revascularization for patients with intermittent claudication: a network metaanalysis. Clin Cardiol. 2015;38:378-86.

    Not in our library10.1002/clc.22406

14. 14.

    Schmit K, Dolor RJ, Jones WS, et al. Comparative effectiveness review of antiplatelet agents in peripheral artery disease. J Am Heart Assoc. 2014;3:e001330.

    Not in our library10.1161/jaha.113.001330

15. 15.

    Jones WS, Dolor RJ, Hasselblad V, et al. Comparative effectiveness of endovascular and surgical revascularization for patients with peripheral artery disease and critical limb ischemia: systematic review of revascularization in critical limb ischemia. Am Heart J. 2014;167:489-98.e7.

    Not in our library10.1016/j.ahj.2013.12.012

16. 16.

    Menard MT, Farber A. The BEST-CLI trial: a multidisciplinary effort to assess whether surgical or endovascular therapy is better for patients with critical limb ischemia. Semin Vasc Surg. 2014;27:82-4.

    Not in our library10.1053/j.semvascsurg.2015.01.003

17. 17.
    Bypass versus angio plasty in severe ischaemia of the leg - 2 (BASIL-2) trial: study protocol for a randomised controlled trial · 2016

    No notice
18. 18.

    Menard MT, Farber A, Assmann SF, et al. Design and rationale of the Best Endovascular Versus Best Surgical Therapy for Patients With Critical Limb Ischemia (BEST-CLI) Trial. J Am Heart Assoc. 2016;5:e003219.

    Not in our library10.1161/jaha.116.003219

19. 19.

    Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics—2016 update: a report from the American Heart Association. Circulation. 2016;133:e38-e360.

    Not in our library10.1161/cir.0000000000000350

20. 20.

    Fowkes FG, Rudan D, Rudan I, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382:1329-40.

    Not in our library10.1016/s0140-6736(13)61249-0

21. 21.

    Creager MA, Belkin M, Bluth EI, et al. 2012 ACCF/AHA/ACR/ SCAI/SIR/STS/SVM/SVN/SVS key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Clinical Data Standards (Writing Committee to develop Clinical Data Standards for Peripheral Atherosclerotic Vascular Disease). Circulation. 2012;125:395-467.

    Not in our library10.1161/cir.0b013e31823299a1

22. 22.

    Rutherford RB, Baker JD, Ernst C, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg. 1997;26:517-38.

    Not in our library10.1016/s0741-5214(97)70045-4

23. 23.

    Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(1):S1-75.

    Not in our library10.1016/j.ejvs.2006.09.024

24. 24.

    Fakhry F, Rouwet EV, den Hoed PT, et al. Long-term clinical effectiveness of supervised exercise therapy versus endovascular revascularization for intermittent claudication from a randomized clinical trial. Br J Surg. 2013;100:1164-71.

    Not in our library10.1002/bjs.9207

25. 25.

    Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation. 2012;125:130-39.

    Not in our library10.1161/circulationaha.111.075770

26. 26.

    Murphy TP, Cutlip DE, Regensteiner JG, et al. Supervised exercise, stent revascularization, or medical therapy for claudication due to aortoiliac peripheral artery disease: the CLEVER study. J Am Coll Cardiol. 2015;65:999-1009.

    Not in our library10.1016/j.jacc.2014.12.043

27. 27.

    Treat-Jacobson D, Bronas UG, Leon AS. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication. Vasc Med. 2009;14:203-13.

    Not in our library10.1177/1358863x08101858

28. 28.

    Hiatt WR, Regensteiner JG, Hargarten ME, et al. Benefit of exercise conditioning for patients with peripheral arterial disease. Circulation. 1990;81:602-9.

    Not in our library10.1161/01.cir.81.2.602

29. 29.

    Parmenter BJ, Dieberg G, Smart NA. Exercise training for management of peripheral arterial disease: a systematic review and meta-analysis. Sports Med. 2015;45:231-44.

    Not in our library10.1007/s40279-014-0261-z

30. 30.

    Parmenter BJ, Dieberg G, Phipps G, et al. Exercise training for health-related quality of life in peripheral artery disease: a systematic review and meta-analysis. Vasc Med. 2015;20:30-40.

    Not in our library10.1177/1358863x14559092

31. 31.

    Pilz M, Kandioler-Honetz E, Wenkstetten-Holub A, et al. Evaluation of 6- and 12-month supervised exercise training on strength and endurance parameters in patients with peripheral arterial disease. Wien Klin Wochenschr. 2014;126:383-9.

    Not in our library10.1007/s00508-014-0548-y

32. 32.

    Regensteiner JG, Steiner JF, Hiatt WR. Exercise training improves functional status in patients with peripheral arterial disease. J Vasc Surg. 1996;23:104-15.

    Not in our library10.1016/s0741-5214(05)80040-0

33. 33.

    Regensteiner JG. Exercise in the treatment of claudication: assessment and treatment of functional impairment. Vasc Med. 1997;2:238-42.

    Not in our library10.1177/1358863x9700200313

34. 34.

    Stewart KJ, Hiatt WR, Regensteiner JG, et al. Exercise training for claudication. N Engl J Med. 2002;347:1941-51.

    Not in our library10.1056/nejmra021135

35. 35.

    Collins TC, Lunos S, Carlson T, et al. Effects of a home-based walking intervention on mobility and quality of life in people with diabetes and peripheral arterial disease: a randomized controlled trial. Diabetes Care. 2011;34:2174-9.

    Not in our library10.2337/dc10-2399

36. 36.

    Fakhry F, Spronk S, de Ridder M, et al. Long-term effects of structured home-based exercise program on functional capacity and quality of life in patients with intermittent claudication. Arch Phys Med Rehabil. 2011;92:1066-73.

    Not in our library10.1016/j.apmr.2011.02.007

37. 37.

    Gardner AW, Parker DE, Montgomery PS, et al. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc. 2014;3:e001107.

    Not in our library10.1161/jaha.114.001107

38. 38.

    Mays RJ, Rogers RK, Hiatt WR, et al. Community walking programs for treatment of peripheral artery disease. J Vasc Surg. 2013;58:1678-87.

    Not in our library10.1016/j.jvs.2013.08.034

39. 39.

    McDermott MM, Domanchuk K, Liu K, et al. The Group Oriented Arterial Leg Study (GOALS) to improve walking performance in patients with peripheral arterial disease. Contemp Clin Trials. 2012;33:1311-20.

    Not in our library10.1016/j.cct.2012.08.001

40. 40.

    McDermott MM, Mehta S. Greenland PExertional leg symptoms other than intermittent claudication are common in peripheral arterial disease. Arch Intern Med. 1999;159:387-92.

    Not in our library10.1001/archinte.159.4.387

Cited by papers we hold 7

• The effect of an 8-week treatment program using a novel foot neuromuscular electrical stimulator on physical function, leg pain, leg symptoms, and leg blood flow in community-dwelling older adults: a randomized sham-controlled trial · 2022
  Not checked
• Abnormal ankle-brachial index, cardiovascular risk factors and healthy lifestyle factors in hypertensive patients: prospective cohort study from a primary care urban population · 2022
  Not checked
• High-Sensitivity Cardiac Troponin Predicts Major Cardiovascular Events in Diabetic Patients With Critical Limb Ischemia and Foot Lesions · 2021
  Not checked
• Triglyceride-glucose index in the development of peripheral artery disease: findings from the Atherosclerosis Risk in Communities (ARIC) Study · 2021
  Not checked
• Platelets as Modulators of Cerebral Ischemia/Reperfusion Injury · 2019
  Not checked
• Limb Ischemia in a Patient with Hyperosmolar Hyperglycemic State · 2018
  Not checked
• Directional Atherectomy Followed by a Paclitaxel-Coated Balloon to Inhibit Restenosis and Maintain Vessel Patency · 2017
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.